Results 11 to 20 of about 991 (120)

SARS‐CoV‐2 infection as cause of in‐utero fetal death: regional multicenter cohort study

Ultrasound in Obstetrics &Gynecology, Volume 62, Issue 6, Page 867-874, December 2023., 2023
ABSTRACT Objective Placental infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) can lead to placental insufficiency and in‐utero fetal death (IUFD). The objective of this study was to confirm and quantify the extent to which fetoplacental infection with SARS‐CoV‐2 is a cause of fetal death.
M. Nkobetchou, M. Leruez‐Ville, T. Guilleminot, N. Roux, G. Petrilli, F. Guimiot, M.‐H. Saint‐Frison, I. Deryabin, Y. Ville, V. Faure‐Bardon   +9 more
wiley   +1 more source

Prediction of fetal and neonatal outcomes after preterm manifestations of placental insufficiency: systematic review of prediction models

Ultrasound in Obstetrics &Gynecology, Volume 62, Issue 5, Page 644-652, November 2023., 2023
ABSTRACT Objectives To identify all prediction models for fetal and neonatal outcomes in pregnancies with preterm manifestations of placental insufficiency (gestational hypertension, pre‐eclampsia, HELLP syndrome or fetal growth restriction with its onset before 37 weeks' gestation) and to assess the quality of the models and their performance on ...
D. G. Kleuskens, C. M. C. van Veen, F. Groenendaal, W. Ganzevoort, S. J. Gordijn, B. B. van Rijn, A. T. Lely, E. Schuit, J. Kooiman   +8 more
wiley   +1 more source

Effect of aspirin on maternal hemodynamics in Chinese women at high risk for preterm pre‐eclampsia: longitudinal study

Ultrasound in Obstetrics &Gynecology, Volume 66, Issue 5, Page 621-630, November 2025.
ABSTRACT Objectives To compare the maternal hemodynamics of Chinese women at low and at high risk for preterm pre‐eclampsia (PE) and assess the differences in hemodynamic parameters between high‐risk women with or without prophylactic aspirin. Methods This was a prospective longitudinal case–control study of 857 Chinese women with a singleton pregnancy
X. Wang, J. Lin, Y. Chen, I. S. Wong, J. Liu, F. Liu, S. L. Lau, Q. Zhang, X. Xu, D. S. Sahota, A. P. W. Lee, L. C. Poon   +11 more
wiley   +1 more source

Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy

Ultrasound in Obstetrics &Gynecology, Volume 66, Issue 5, Page 641-648, November 2025.
ABSTRACT Objective To evaluate the impact of low‐dose aspirin (LDA) on placental size and uterine artery pulsatility index (UtA‐PI) by analyzing longitudinal changes between the first and second trimesters in pregnancies at high risk for early‐onset pre‐eclampsia (PE).
C. Trilla, J. Platero, J. Mora, M. N. Nan, C. Medina, O. Alejos, J. Parra, E. Llurba   +7 more
wiley   +1 more source

Comparison of open fetal, fetoscopic and postnatal surgical repair for open spina bifida: decision analysis

Ultrasound in Obstetrics &Gynecology, Volume 66, Issue 4, Page 433-442, October 2025.
ABSTRACT Objective Currently, there are several surgical approaches to manage fetal open spina bifida (OSB), namely postnatal surgical repair, open fetal surgery and its minimally invasive alternative, fetoscopic repair. Our objective was to determine the optimal surgical approach for OSB, weighing the benefits and risks to the fetus and the pregnant ...
Y. Kunpalin, Y. Sahakyan, B. Sander, J. W. Snelgrove, K. Raghuram, A. V. Kulkarni, T. Van Mieghem   +6 more
wiley   +1 more source

Benefits and complications of fetal and postnatal surgery for open spina bifida: systematic review and proportional meta‐analysis

Ultrasound in Obstetrics &Gynecology, Volume 66, Issue 2, Page 135-146, August 2025.
ABSTRACT Objective To derive pooled estimates of maternal, fetal and pediatric outcomes up to the age of 30 months in patients undergoing pre‐ or postnatal surgery for open spina bifida (OSB). Methods A systematic search was conducted in MEDLINE, PubMed (non‐MEDLINE records), Embase, Web of Science, ClinicalTrials.gov, Cochrane Central Register of ...
Y. Kunpalin, V. S. Karadjole, E. S. B. Medeiros, M. Domínguez‐Moreno, J. Sichitiu, N. Abbasi, G. Ryan, S. Shinar, J. W. Snelgrove, A. V. Kulkarni, T. Van Mieghem   +10 more
wiley   +1 more source

Placental biomarker and fetoplacental Doppler abnormalities are strongly associated with placental pathology in pregnancies with small‐for‐gestational‐age fetus: prospective study

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 6, Page 749-760, June 2025.
ABSTRACT Objective Placental dysfunction can result in small‐for‐gestational age (SGA) or fetal growth restriction (FGR). The aim of this prospective cohort study was to assess the association of the cerebroplacental ratio (CPR) and other more conventional fetoplacental Doppler indices, circulating placental growth factor (PlGF) levels and soluble fms ...
J. Hong, K. Crawford, E. Cavanagh, V. Clifton, F. da Silva Costa, A. V. Perkins, S. Kumar   +6 more
wiley   +1 more source

Automated multivolume placental reconstruction using three‐dimensional power Doppler ultrasound and infrared camera tracking

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 5, Page 624-632, May 2025.
ABSTRACT Objectives Placental insufficiency contributes to many obstetric pathologies, but there is no bedside clinical tool to evaluate placental perfusion. We have developed a method to acquire multiple three‐dimensional (3D) power Doppler (PD) ultrasound (US) volumes of placental vasculature, with infrared camera tracking of the precise spatial ...
A. Xue, R. Hanly, D. Luichareonkit, S. Thomas, T. Barber, A. W. Welsh   +5 more
wiley   +1 more source

Screening for pre‐eclampsia using pregnancy‐associated plasma protein‐A or placental growth factor measurements in blood samples collected at 8–14 weeks' gestation

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 5, Page 567-574, May 2025.
ABSTRACT Objectives To assess the value of pregnancy‐associated plasma protein‐A (PAPP‐A) in screening for preterm pre‐eclampsia (PE) (delivery < 37 weeks' gestation) measured in maternal blood samples collected before 11 weeks, and to compare the screening performance of PAPP‐A with that of placental growth factor (PlGF) from blood samples collected ...
L. Rode, A. Wright, D. Wright, M. Overgaard, L. Sperling, P. Sandager, P. Nørgaard, F. S. Jørgensen, H. Zingenberg, I. Riishede, A. Tabor, C. K. Ekelund, the PRESIDE Study Group, M. R. Andersen, L. Bathum, C. A. Juel Jensen, C. S. Knudsen, N. G. Pedersen, K. Pihl, C. Vedel, H. Skov, S. R. Wagner   +21 more
wiley   +1 more source

Detection of human cytomegalovirus cell‐free DNA in pregnant women with symptomatically infected fetuses: proof‐of‐concept study

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 4, Page 470-477, April 2025.
ABSTRACT Objective To evaluate the presence and levels of cytomegalovirus (CMV) cell‐free DNA (cfDNA) fragments in women pregnant with a fetus with symptomatic congenital CMV (cCMV). Methods The study comprised nine women whose fetuses were diagnosed with cCMV between June 2019 and July 2024 at 20 + 4 to 34 + 1 weeks' gestation (n = 8) or neonatally (n 
B. H. W. Faas, T. Meuleman, G. Astuti, A. Reuss, K. Stol, E. A. Sistermans, J. Linthorst, E. van Leeuwen, J. Rahamat‐Langendoen, F. A. Wilmink   +9 more
wiley   +1 more source